Figure 4.
Expression of miR-381 in the (A) plaque tissues, (B) PBMCs and (C) serum of healthy subjects and patients with coronary atherosclerosis. Reverse transcription-quantitative polymerase chain reaction was used to determine the expression of miR-381. *P<0.05 and **P<0.01 vs. the control group. COX-2, cyclooxygenase-2; PBMCs, peripheral blood mononuclear cells; miR, microRNA.